1z6e
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:1z6e.gif|left|200px]] | + | [[Image:1z6e.gif|left|200px]] |
- | + | ||
- | '''Crystal Structure of Factor Xa complexed to Razaxaban''' | + | {{Structure |
+ | |PDB= 1z6e |SIZE=350|CAPTION= <scene name='initialview01'>1z6e</scene>, resolution 1.8Å | ||
+ | |SITE= | ||
+ | |LIGAND= <scene name='pdbligand=IK8:1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-{2-[(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE'>IK8</scene> | ||
+ | |ACTIVITY= [http://en.wikipedia.org/wiki/Coagulation_factor_Xa Coagulation factor Xa], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.6 3.4.21.6] | ||
+ | |GENE= | ||
+ | }} | ||
+ | |||
+ | '''Crystal Structure of Factor Xa complexed to Razaxaban''' | ||
+ | |||
==Overview== | ==Overview== | ||
Line 10: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | 1Z6E is a [ | + | 1Z6E is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Z6E OCA]. |
==Reference== | ==Reference== | ||
- | Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor., Quan ML, Lam PY, Han Q, Pinto DJ, He MY, Li R, Ellis CD, Clark CG, Teleha CA, Sun JH, Alexander RS, Bai S, Luettgen JM, Knabb RM, Wong PC, Wexler RR, J Med Chem. 2005 Mar 24;48(6):1729-44. PMID:[http:// | + | Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor., Quan ML, Lam PY, Han Q, Pinto DJ, He MY, Li R, Ellis CD, Clark CG, Teleha CA, Sun JH, Alexander RS, Bai S, Luettgen JM, Knabb RM, Wong PC, Wexler RR, J Med Chem. 2005 Mar 24;48(6):1729-44. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/15771420 15771420] |
[[Category: Coagulation factor Xa]] | [[Category: Coagulation factor Xa]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Line 37: | Line 46: | ||
[[Category: factor xa]] | [[Category: factor xa]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Mar 20 15:31:41 2008'' |
Revision as of 13:31, 20 March 2008
| |||||||
, resolution 1.8Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | |||||||
Activity: | Coagulation factor Xa, with EC number 3.4.21.6 | ||||||
Coordinates: | save as pdb, mmCIF, xml |
Crystal Structure of Factor Xa complexed to Razaxaban
Contents |
Overview
Modification of a series of pyrazole factor Xa inhibitors to incorporate an aminobenzisoxazole as the P(1) ligand resulted in compounds with improved selectivity for factor Xa relative to trypsin and plasma kallikrein. Further optimization of the P(4) moiety led to compounds with enhanced permeability and reduced protein binding. The SAR and pharmacokinetic profile of this series of compounds is described herein. These efforts culminated in 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4-[(2'-dimeth ylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide (11d), a potent, selective, and orally bioavailable inhibitor of factor Xa. On the basis of its excellent in vitro potency and selectivity profile, high free fraction in human plasma, good oral bioavailability, and in vivo efficacy in antithrombotic models, the HCl salt of this compound was selected for clinical development as razaxaban (DPC 906, BMS-561389).
Disease
Known disease associated with this structure: Factor X deficiency OMIM:[227600]
About this Structure
1Z6E is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Discovery of 1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2'-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor., Quan ML, Lam PY, Han Q, Pinto DJ, He MY, Li R, Ellis CD, Clark CG, Teleha CA, Sun JH, Alexander RS, Bai S, Luettgen JM, Knabb RM, Wong PC, Wexler RR, J Med Chem. 2005 Mar 24;48(6):1729-44. PMID:15771420
Page seeded by OCA on Thu Mar 20 15:31:41 2008
Categories: Coagulation factor Xa | Homo sapiens | Protein complex | Alexander, R S. | Bai, S. | Clark, C G. | Ellis, C D. | Han, Q. | He, M Y. | Knabb, R M. | Lam, P Y.S. | Li, R. | Luettgen, J M. | Pinto, D J.P. | Quan, M L. | Sun, J H. | Teleha, C A. | Wexler, R R. | Wong, P C. | IK8 | Coagulation cascade | Factor xa